Medicines and Healthcare products Regulatory Agency authorises GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults
PharmiWeb,
Authorisation will help protect adults 60 years of age and older in the UK from RSV disease for the first time In the UK, RSV…